Project Grant HT94252510835
Award Date 10/1/25
Completion Date 9/30/27
Dollars Obligated $696K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
- This $949,181 federal Project Grant award was provided by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research by the Icahn School of Medicine at Mount Sinai to investigate the association between cortical lesions and physical/cognitive disability in multiple sclerosis using novel, clinically feasible MRI methods. The research aims to advance the understanding and treatment of multiple sclerosis, a...
- The U.S. Department of Defense's Defense Health Agency awarded a $633,750.00 Project Grant to the Icahn School of Medicine at Mount Sinai in New York, NY under the Military Medical Research and Development (CFDA 12.420) program. This grant will fund a 3-year research project focused on "INTERPLAY BETWEEN SENSORY NEURONS AND NK CELLS DURING BREAST CANCER METASTATIC DORMANCY", with a performance period from Aug 1, 2025 to Jul 31, 2028. The Icahn School of Medicine at Mount Sinai is a...
- The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
- The federal Project Grant award of $7,694,338.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "LIVEWELL: LIVING WITH VIOLENCE-RELATED BRAIN INJURY: OPTIMIZING COGNITIVE AND PSYCHOLOGICAL WELLNESS THROUGH THE LIVEWELL BRAIN HEALTH STUDY" research project. The award was granted to the Icahn School of Medicine at Mount Sinai, a leading academic medical center and research institution, to conduct advanced...
- The Project Grant award of $3,300,817.00 from the U.S. Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research by the Icahn School of Medicine at Mount Sinai (ISMMS) to leverage personalized stem cell therapy to overcome airway reconstruction. This 4-year grant, awarded on June 1, 2025, will fund innovative and impactful research to transform healthcare for military service members and the public through the...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,014,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The research, which is scheduled to take place from September 1, 2024 to August 31, 2028, will leverage the institution's expertise in areas such as cancer biology, immunology, and clinical...
- The Defense Health Agency awarded a $456,633 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant funds the development and optimization of a platform for next-generation monoclonal antibodies against Powassan virus and other neuroinvasive tick-borne viruses. Key collaborators include researchers from the United States Army Medical Research Institute of Infectious...
- This federal Project Grant award of $553,189.00 was issued on September 1, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to Weill Medical College of Cornell University to conduct research on "CIRCULATING ANTIBODY REPERTOIRE AND BLOOD-BRAIN-BARRIER IMPAIRMENT TO EXPLAIN NEUROPSYCHIATRIC SYMPTOMS OF 'INVISIBLE' BRAIN INJURY". The research aims to transform healthcare for military service members,...
- This $859,773 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to Yale University supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The funding will enable research on "BIOMARKERS AND TARGETS OF LEPTOMENINGEAL DISEASE PROGRESSION FROM NSCLC BRAIN METASTASIS" over the period of May 1, 2025 to April 30, 2028. The research...